Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine

Addiction Biology

Volumn 19, Issue 3, 2014, Pages 370-379

  Eastwood, Emily C ^a   Phillips, Tamara J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Amphetamine; selective breeding; opioid receptor

Indexed keywords

FENTANYL CITRATE; METHAMPHETAMINE; MORPHINE SULFATE; OPIATE; CENTRAL STIMULANT AGENT; FENTANYL; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; BREEDING; CONTROLLED STUDY; DBA 2 MOUSE; DRUG EFFECT; DRUG ELIMINATION; DRUG SENSITIVITY; FEMALE; GENETIC CORRELATION; HOT PLATE TEST; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TAIL FLICK TEST; ANIMAL; C57BL MOUSE; CHRONIC PAIN; DBA MOUSE; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECTS; GENETICS; INSTRUMENTAL CONDITIONING; MOLECULAR GENETICS; MOTOR ACTIVITY; OPIATE ADDICTION; PAIN MEASUREMENT; PATHOPHYSIOLOGY;

AMPHETAMINE-RELATED DISORDERS; ANALGESICS, OPIOID; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC PAIN; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; MALE; METHAMPHETAMINE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; MORPHINE; MOTOR ACTIVITY; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU;

EID: 84898950218     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12003     Document Type: Article

References (41)

1. Altier N, Stewart J, (1999) The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65: 2269-2287.
2. Barton C, Basbaum AI, Fields HL, (1980) Dissociation of supraspinal and spinal actions of morphine: a quantitative evaluation. Brain Res 188: 487-498.
3. Basbaum AI, Fields HL, (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309-338.
4. Belknap JK, Crabbe JC, Young ER, (1993) Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 112: 503-510.
5. Belknap JK, Mogil JS, Helms ML, Richards SP, O'Toole LA, Bergeson SE, Buck KJ, (1995) Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci 57: PL117-PL124.
6. Belknap JK, Noordewier B, Lame M, (1989) Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav 46: 69-74.
7. Belknap JK, Richards SP, O'Toole LA, Helms ML, Phillips TJ, (1997) Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behav Genet 27: 55-66.
8. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, Mogil JS, Belknap JK, (2001) Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 12: 546-553.
9. Berrettini WH, Alexander R, Ferraro TN, Vogel WH, (1994a) A study of oral morphine preference in inbred mouse strains. Psychiatr Genet 4: 81-86.
10. Berrettini WH, Ferraro TN, Alexander RC, Buchberg AM, Vogel WH, (1994b) Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet 7: 54-58.
11. Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA, (2009a) A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav 8: 795-805.
12. Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS, (2009b) Pavlovian conditioning of multiple opioid-like responses in mice. Drug Alcohol Depend 103: 74-83.
13. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G, (2000) Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92: 465-472.
14. Chiu CT, Ma T, Ho IK, (2005) Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull 67: 100-109.
15. Crabbe JC, Phillips TJ, Kosobud A, Belknap JK, (1990) Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res 14: 141-151.
16. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D, (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1): 227-241.
17. Doyle GA, Rebecca Sheng X, Lin SS, Press DM, Grice DE, Buono RJ, Ferraro TN, Berrettini WH, (2007) Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene 388: 135-147.
18. Doyle GA, Sheng XR, Schwebel CL, Ferraro TN, Berrettini WH, Buono RJ, (2006) Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice. Neurosci Res 55: 244-254.
19. Ferraro TN, Golden GT, Smith GG, Martin JF, Schwebel CL, Doyle GA, Buono RJ, Berrettini WH, (2005) Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains. Neuropsychopharmacology 30: 742-746.
20. Hendershot LC, Forsaith J, (1959) Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther 125: 237-240.
21. Ide S, Han W, Kasai S, Hata H, Sora I, Ikeda K, (2005) Characterization of the 3′ untranslated region of the human mu-opioid receptor (MOR-1) mRNA. Gene 364: 139-145.
22. Ide S, Kobayashi H, Tanaka K, Ujike H, Sekine Y, Ozaki N, Inada T, Harano M, Komiyama T, Yamada M, Iyo M, Ikeda K, Sora I, (2004) Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci 1025: 316-324.
23. Johnson SW, North RA, (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
24. Jones DN, Holtzman SG, (1994) Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacology 114: 215-224.
25. Kalvass JC, Olson ER, Cassidy MP, Selley DE, Pollack GM, (2007) Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein- competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther 323: 346-355.
26. Luo P, Wong YF, Ge L, Zhang ZF, Liu Y, Liu L, Zhou H, (2010) Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther 335: 735-742.
27. Mogil JS, Kest B, Sadowski B, Belknap JK, (1996) Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J Pharmacol Exp Ther 276: 532-544.
28. Mogil JS, Marek P, Flodman P, Spence MA, Sternberg WF, Kest B, Sadowski B, Liebeskind JC, (1995) One or two genetic loci mediate high opiate analgesia in selectively bred mice. Pain 60: 125-135.
29. Phillips TJ, Burkhart-Kasch S, Gwiazdon CC, Crabbe JC, (1992a) Locomotor responses of FAST and SLOW mice to several alcohols and drugs of abuse. Ann N Y Acad Sci 654: 499-501.
30. Phillips TJ, Burkhart-Kasch S, Gwiazdon CC, Crabbe JC, (1992b) Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity. J Pharmacol Exp Ther 261: 525-533.
31. Phillips TJ, Crabbe JC, Metten P, Belknap JK, (1994) Localization of genes affecting alcohol drinking in mice. Alcohol Clin Exp Res 18: 931-941.
32. Phillips TJ, Huson M, Gwiazdon C, Burkhart-Kasch S, Shen EH, (1995) Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res 19: 269-278.
33. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T, (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45: 330-334.
34. Romero A, Miranda HF, Puig MM, (2010) Antinociceptive effects of morphine, fentanyl, tramadol and their combination, in morphine-tolerant mice. Pharmacol Biochem Behav 97: 363-369.
35. Shabani S, Dobbs LK, Ford MM, Mark GP, Finn DA, Phillips TJ, (2012a) A genetic animal model of differential sensitivity to methamphetamine reinforcement. Neuropharmacology 62: 2169-2177.
36. Shabani S, McKinnon CS, Cunningham CL, Phillips TJ, (2012b) Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology 62: 1134-1141.
37. Shabani S, McKinnon CS, Reed C, Cunningham CL, Phillips TJ, (2011) Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake. Genes Brain Behav 10: 625-636.
38. Shen X, Purser C, Tien LT, Chiu CT, Paul IA, Baker R, Loh HH, Ho IK, Ma T, (2010) mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res 88: 2294-2302.
39. Taber KH, Black DN, Porrino LJ, Hurley RA, (2012) Neuroanatomy of dopamine: reward and addiction. J Neuropsychiatry Clin Neurosci 24: 1-4.
40. Volpe DA, McMahon Tobin GA, Mellon RD, Katki AG, Parker RJ, Colatsky T, Kropp TJ, Verbois SL, (2011) Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol 59: 385-390.
41. Wheeler JM, Reed C, Burkhart-Kasch S, Li N, Cunningham CL, Janowsky A, Franken FH, Wiren KM, Hashimoto JG, Scibelli AC, Phillips TJ, (2009) Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes Brain Behav 8: 758-771.